Suchergebnisse - "Charton, E"

PubPharm (31)

1

Ph. Eur. testing for histamine and depressor substances using guinea-pigs and cats : the end of an era. Strategy for removal of animal tests for histamine and depressor substances and their vestiges from the Ph. Eur

enthalten in: Pharmeuropa bio & scientific notes | 2024

von Bratos, M. | Kolaj-Robin, O. | Antoni, M. | +1

2

Inequality factors in access to early-phase clinical trials in oncology in France : results of the EGALICAN-2 study

enthalten in: ESMO open | 2023

von Charton, E. | Baldini, C. | Fayet, Y. | +21

3

Informal investigation on the added value of a potential certification system for the qualification of raw materials for the production of ATMPs

enthalten in: Pharmeuropa bio & scientific notes | 2023

von Le Maux, S. | Closson-Carella, V. | Kolaj-Robin, O. | +2

4

Access to early-phase clinical trials in older patients with cancer in France : the EGALICAN-2 study

enthalten in: ESMO open | 2022

von Baldini, C. | Charton, E. | Schultz, E. | +19

5

%TTD and %TUDD : New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

enthalten in: Computer methods and programs in biomedicine | 2022

von Charton, E. | Falcoz, A. | François, E. | +6

6

Handling informative dropout in longitudinal analysis of health-related quality of life : application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

enthalten in: BMC medical research methodology | 2020

von Cuer, B. | Mollevi, C. | Anota, A. | +4

7

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

enthalten in: BMC medical research methodology | 2020

von Cuer, B. | Mollevi, C. | Anota, A. | +4

8

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

enthalten in: BMC medical research methodology | 2020

von Cuer, B. | Mollevi, C. | Anota, A. | +4

9

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data : a systematic review

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2020

von Charton, E. | Cuer, B. | Cottone, F. | +8

10

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review

enthalten in: Quality of life research | 2019

von Charton, E. | Cuer, B. | Cottone, F. | +8